Prognostic value of HER2 expression in cervical adenocarcinoma: A retrospective cohort study.

Oncol Lett · 2025 · PMC11907399 · PMID 40093868

Europe PMC DOI

hedged sentence

0.1500

closest p · 3.0× alpha

0.1500

boldest claim

The sentences

did not reach statistical significanceP=0.15not close (p > 0.1)

Among the tumor markers, abnormal pre-treatment CA-125 levels were significantly associated with HER2 expression (P=0.023), whereas pre-treatment CA19-9 levels did not reach statistical significance (P=0.15).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.